BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26308394)

  • 1. Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis.
    Agrawal R; Lee CS; Gonzalez-Lopez JJ; Khan S; Rodrigues V; Pavesio C
    Ocul Immunol Inflamm; 2016; 24(1):35-42. PubMed ID: 26308394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleritis therapy.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of therapeutic decision for scleritis.
    Sainz de la Maza M; Jabbur NS; Foster CS
    Ophthalmology; 1993 Sep; 100(9):1372-6. PubMed ID: 8371926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis.
    Sohn EH; Wang R; Read R; Roufas A; Teo L; Moorthy R; Albini T; Vasconcelos-Santos DV; Dustin LD; Zamir E; Chee SP; McCluskey P; Smith R; Rao N
    Ophthalmology; 2011 Oct; 118(10):1932-7. PubMed ID: 21708408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis.
    Bauer AM; Fiehn C; Becker MD
    Am J Ophthalmol; 2005 Jun; 139(6):1086-9. PubMed ID: 15953441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclo-oxygenase inhibitors in the treatment of chronic non-infectious, non-necrotizing scleritis and episcleritis.
    Kolomeyer AM; Ragam A; Shah K; Do BK; Shah VP; Chu DS
    Ocul Immunol Inflamm; 2012 Aug; 20(4):293-9. PubMed ID: 22642498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis and management of anterior scleritis.
    Albini TA; Rao NA; Smith RE
    Int Ophthalmol Clin; 2005; 45(2):191-204. PubMed ID: 15791166
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic decision in anterior scleritis: our experience at a tertiary care eye center.
    Carrasco MA; Cohen EJ; Rapuano CJ; Laibson PR
    J Fr Ophtalmol; 2005 Dec; 28(10):1065-9. PubMed ID: 16395198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleritis.
    Cunningham ET; McCluskey P; Pavesio C; Wakefield D; Zierhut M
    Ocul Immunol Inflamm; 2016; 24(1):2-5. PubMed ID: 26872551
    [No Abstract]   [Full Text] [Related]  

  • 10. Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.
    Knickelbein JE; Tucker WR; Bhatt N; Armbrust K; Valent D; Obiyor D; Nussenblatt RB; Sen HN
    Am J Ophthalmol; 2016 Dec; 172():104-110. PubMed ID: 27663070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episcleritis and scleritis: clinical features and treatment results.
    Jabs DA; Mudun A; Dunn JP; Marsh MJ
    Am J Ophthalmol; 2000 Oct; 130(4):469-76. PubMed ID: 11024419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scleritis, clinical features, etiologies and treatment: a case series of 32 patients].
    Leal C; Le Roux K; Rahmi A; Varron L; Broussolle C; Denis P; Kodjikian L; Sève P
    Rev Med Interne; 2014 Aug; 35(8):491-7. PubMed ID: 24210266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of topical steroid therapy in the management of nonnecrotizing anterior scleritis.
    McMullen M; Kovarik G; Hodge WG
    Can J Ophthalmol; 1999 Jun; 34(4):217-21. PubMed ID: 10396658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience With 0.1% Tacrolimus Eye Drop for Noninfectious, Non-necrotizing Anterior Scleritis.
    Yazu H; Miyazaki D; Fujishima H
    Eye Contact Lens; 2021 Apr; 47(4):185-190. PubMed ID: 32404650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Profile of Patients with Necrotizing Scleritis in a Tertiary Eye Care Center in Southern India.
    Dutta Majumder P; Ghose A; Chidambaram M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2018; 26(3):412-416. PubMed ID: 27762661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis.
    Albini TA; Zamir E; Read RW; Smith RE; See RF; Rao NA
    Ophthalmology; 2005 Oct; 112(10):1814-20. PubMed ID: 16199269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of Scleritis in an Egyptian Cohort.
    Abd El Latif E; Seleet MM; El Hennawi H; Abdulbadiea Rashed M; Elbarbary H; Sabry K; Abdelmonagy Ibrahim M
    Ocul Immunol Inflamm; 2019; 27(6):890-896. PubMed ID: 30412434
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis.
    Zamir E; Read RW; Smith RE; Wang RC; Rao NA
    Ophthalmology; 2002 Apr; 109(4):798-805; discussion 805-7. PubMed ID: 11927443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Profile, Systemic Association, Treatment and Visual Outcome of Patients with Scleritis in an Eye Care Center in Mexico City.
    Suarez Avellaneda NA; Bobadilla Marroquin Y; Rodriguez Lopez CE; Loya Carrera MF; Pedroza-Seres M
    Ocul Immunol Inflamm; 2023 Apr; 31(3):550-555. PubMed ID: 35258418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trial.
    Bhatt N; Dalal M; Tucker W; Obiyor D; Nussenblatt R; Sen HN
    Am J Ophthalmol; 2015 Mar; 159(3):601-6. PubMed ID: 25526946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.